Stock listing

Frankfurt:J7Z Jazz Pharmaceuticals plc Aktie

German listing (Frankfurt) of Jazz Pharmaceuticals plc · home listing NASDAQ:JAZZ

Follow Jazz Pharmaceuticals plc into a list and get an email when it puts out news.

Share price · FWB:J7Z

€192.90 EUR +7.40 (+4.0%)

Close on Oct 30, 2026

Day range
€184.20 – €192.90 EUROct 30, 2026
Market cap
€12.52B EURAt the close on Oct 30, 2026 · price × 64.91M shares outstanding
Jazz Pharmaceuticals plc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:JAZZ · Home$215.98 USD+8.15 (+3.9%)1,212,681$209.63$216.38$209.36$207.83Close on Oct 30, 2026
Frankfurt:J7Z€192.90 EUR+7.40 (+4.0%)—€184.20€192.90€184.20€185.50Close on Oct 30, 2026
Ticker
Frankfurt:J7Z
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Jazz Pharmaceuticals (NASDAQ:JAZZ) Q3 2026 Earnings Call

    Mon, Nov 02, 2026 · 4:30 PM ET

    Watch

  • Jazz Pharmaceuticals (NASDAQ:JAZZ) Q2 2026 Earnings Call

    Mon, Aug 03, 2026 · 4:30 PM ET

    Watch Transcript

  • Jazz Pharmaceuticals (NASDAQ:JAZZ) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results

Nov 2, 2026

Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026

Oct 23, 2026

Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 2, 2026

Oct 19, 2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Sep 15, 2026

Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA

Aug 31, 2026

Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

Aug 27, 2026

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

Aug 26, 2026

Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio

Aug 10, 2026

Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results

Aug 3, 2026

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026

Jul 20, 2026

All Jazz Pharmaceuticals plc news

Financings

Read by 6ix AI from the company's releases

Decks

Jazz Pharmaceuticals plc on 6ix

News releases
41 in the last 12 months · 273 in all · newest Nov 2, 2026 · oldest 2019
Calls
18 calls with a replay · 17 with a transcript · latest Nov 2, 2026
Decks
37 decks · latest September 2026

Where Jazz Pharmaceuticals plc is listed

ListingExchangeCountryCurrency
NASDAQ:JAZZ · Home listingNASDAQUnited StatesUSD
Tradegate:J7ZTradegateGermanyEUR
gettex:J7ZgettexGermanyEUR
LS Exchange:A1JS1KLS ExchangeGermanyEUR
Frankfurt:J7Z · This pageFrankfurtGermanyEUR
Lang & Schwarz:A1JS1KLang & SchwarzGermanyEUR
BOATS:JAZZBOATSUnited StatesUSD
Milan:1JAZZMilanItalyEUR
B3:J2AZ34B3BrazilBRL
BMV:JAZZNBMVMexicoMXN
Stuttgart:J7ZStuttgartGermanyEUR
BIVA:JAZZNBIVAMexicoMXN
BX Swiss:J7ZBX SwissSwitzerlandCHF
Dusseldorf:J7ZDusseldorfGermanyEUR
Hamburg:J7ZHamburgGermanyEUR
Hanover:J7ZHanoverGermanyEUR
Munich:J7ZMunichGermanyEUR
Xetra:J7ZXetraGermanyEUR

Log in to ask 6ix AI your own questions about Jazz Pharmaceuticals plc.